PATENT CLAIM ANALYSIS

Application Number: 16309557
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["514", "017800"]

Abstract:
The present invention provides a peptide consisting of the amino acid sequence of SEQ ID NO:1 or the amino acid sequence of SEQ ID NO:2, or a pharmaceutically acceptable salt thereof and a use thereof. The present invention can inhibit the entry of beta-amyloid into the brain. In addition, the present invention can be applied more easily with respect to the suppression of the intracerebral action of beta-amyloid and thus is advantageous in having excellent applicability.

Claim (Index 3):
A pharmaceutical composition for treatment or prevention of at least one selected from among Alzheimer's disease, dementia, Parkinson's disease, Huntington's disease, and inflammation of a brain, comprising the peptide or the pharmaceutically acceptable salt thereof of  claim 1 .

Metadata:
- Claim Count in Document: 9.0
- Percentile: 98.0
- Lexical Diversity: 1.62
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15146255', '13602913', '12064146', '13213960', '15545399']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5302725981612616
- 35 USC 102 Novelty (BERT): 0.5008731938141393
- Combined Prediction Score: 0.5273326577265494
- Mean Citation Score: 200.67594
- Max Citation Score: 204.33623
- Similarity Product: 141.23235844297528

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test